Suchergebnisse - "O'Day, Steven J"

PubPharm (117)

61

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

enthalten in: BMC cancer | 2009

von Eager, R. | Cunningham, C. | Senzer, N. | +8

62

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

enthalten in: BMC cancer | 2009

von Eager, R. | Cunningham, C. | Senzer, N. | +8

63

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

enthalten in: BMC cancer | 2009

von Eager, R. | Cunningham, C. | Senzer, N. | +8

64

mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads

enthalten in: Clinical chemistry | 2009

von Kitago, M. | Koyanagi, K. | Nakamura, T. | +6

65

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

in: BMC Cancer | 2009

von Anthony Stephen P | Stephenson Joe | Senzer Neil N | +8

66

mRNA Expression and BRAF Mutation in Circulating Melanoma Cells Isolated from Peripheral Blood with High Molecular Weight Melanoma-Associated Antigen-Specific Monoclonal Antibody Beads

enthalten in: Clinical chemistry | 2009

von Kitago, M. | Koyanagi, K. | Nakamura, T. | +6

67

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma

enthalten in: Clinical cancer research | 2009

von Weber, J. | Thompson, J. | Hamid, O. | +9

68

Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) : a novel strategy for the treatment of melanoma and other malignancies

enthalten in: Cancer | 2007

von O'Day, S. | Hamid, O. | Urba, W.

69

Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2007

von Shinozaki, M. | O'Day, S. | Kitago, M. | +5

70

Utility of Circulating B-RAF DNA Mutation in Serum for Monitoring Melanoma Patients Receiving Biochemotherapy

enthalten in: Clinical cancer research | 2007

von Shinozaki, M. | O'Day, S. | Kitago, M. | +5